Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

0

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plcPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

0

EQS-News: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png

EQS-News: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform

EQS-News: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform

0

EQS-Adhoc: Multitude SE Contemplates a Relocation to SwitzerlandPhoto, wide shot, wide-angle lens, soft focus, Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D

EQS-Adhoc: Multitude SE Contemplates a Relocation to Switzerland

EQS-Adhoc: Multitude SE Contemplates a Relocation to Switzerland

0

EQS-News: Nicole Schillinger is joining Cherry SE as Senior Vice President Investor Relations

EQS-News: Nicole Schillinger is joining Cherry SE as Senior Vice President Investor Relations

EQS-News: Nicole Schillinger is joining Cherry SE as Senior Vice President Investor Relations

0

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim BiotechPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

0

Transaction in Own SharesPhoto, wide shot, wide-angle lens, soft focus, Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D

Transaction in Own Shares

Transaction in Own Shares

0

Cairn Homes Plc: Transaction in Own SharesPhoto, wide shot, wide-angle lens, Toy manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/2788fcd3-d339-4592-8f5c-a3b9125dc61f.png

Cairn Homes Plc: Transaction in Own Shares

Cairn Homes Plc: Transaction in Own Shares

0

Custodian Property Income REIT plc: Interim dividend

Custodian Property Income REIT plc: Interim dividend

Custodian Property Income REIT plc: Interim dividend

0

Publication of Circular and RTW Bio Prospectus

Publication of Circular and RTW Bio Prospectus

Publication of Circular and RTW Bio Prospectus

0

EQS-News: Fielmann Group bids farewell to its founder Guenther FielmannPhoto, wide shot, wide-angle lens, Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/add1012b-1b24-4eb2-aba0-77ab52c7f8ad.png

EQS-News: Fielmann Group bids farewell to its founder Guenther Fielmann

EQS-News: Fielmann Group bids farewell to its founder Guenther Fielmann

0

RM plc: Holding(s) in Company:

RM plc: Holding(s) in Company

RM plc: Holding(s) in Company

0

Britvic plc Director/PDMR ShareholdingPhoto, wide shot, wide-angle lens, Restaurant, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/57273392-070f-46de-9297-125616327242.png

Britvic plc Director/PDMR Shareholding

Britvic plc Director/PDMR Shareholding

0

EQS-News: Formycon to present at the 42nd Annual J.P. Morgan Healthcare ConferencePhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

EQS-News: Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference

EQS-News: Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference

0

DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

0

INSPIRE MEDICAL INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Inspire Medical Investors of a Class Action Lawsuit and Upcoming DeadlinePhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

INSPIRE MEDICAL INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline

INSPIRE MEDICAL INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline

0

TUI AG: PUBLICATION OF CIRCULAR AND NOTICE OF PROPOSED UK DELISTING RESOLUTION: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png

TUI AG: PUBLICATION OF CIRCULAR AND NOTICE OF PROPOSED UK DELISTING RESOLUTION

TUI AG: PUBLICATION OF CIRCULAR AND NOTICE OF PROPOSED UK DELISTING RESOLUTION

0

TUI AG: NOTICE OF 2024 ANNUAL GENERAL MEETING: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png

TUI AG: NOTICE OF 2024 ANNUAL GENERAL MEETING

TUI AG: NOTICE OF 2024 ANNUAL GENERAL MEETING

0

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plcPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

0

EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy Photo, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy

EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy

0

EQS-News: NEON EQUITY AG supports GORE German Office Real Estate in structuring and implementing the non-cash capital increase

EQS-News: NEON EQUITY AG supports GORE German Office Real Estate in structuring and implementing the non-cash capital increase

EQS-News: NEON EQUITY AG supports GORE German Office Real Estate in structuring and implementing the non-cash capital increase

0

Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31

Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31

Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31

0

u-blox module unlocks new automotive use casesPhoto, wide shot, wide-angle lens, Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.midjourneyapi.xyz/temp/568784d0-c41a-4663-ab01-91f29a370903.png

u-blox module unlocks new automotive use cases

u-blox module unlocks new automotive use cases

0

Nordea Bank Abp: Repurchase of own shares on 03.01.2024Photo, wide shot, wide-angle lens, soft focus, Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D

Nordea Bank Abp: Repurchase of own shares on 03.01.2024

Nordea Bank Abp: Repurchase of own shares on 03.01.2024

0

EQS-News: Abivax 2024 Financial Communication CalendarPhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

EQS-News: Abivax 2024 Financial Communication Calendar

EQS-News: Abivax 2024 Financial Communication Calendar

0